Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2016 1
2017 1
2019 1
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Definitive radiotherapy consisting of external beam radiotherapy without central shielding and 3D image-guided brachytherapy for patients with cervical cancer: feasibility for Japanese patients and dose-response analyses for local control in the low-dose range.
Toita T, Wada K, Sutani S, Umezawa R, Maemoto H, Ii N, Kawamura T, Ikushima H, Takenaka R, Konishi K, Yorozu A, Jingu K, Ariga T, Nomoto Y, Yamashita H. Toita T, et al. Among authors: takenaka r. Jpn J Clin Oncol. 2023 Jun 1;53(6):480-488. doi: 10.1093/jjco/hyad022. Jpn J Clin Oncol. 2023. PMID: 36974716
Injection of hydrogel spacer increased maximal intrafractional prostate motion in anterior and superior directions during volumetric modulated arc therapy-stereotactic body radiation therapy for prostate cancer.
Sawayanagi S, Yamashita H, Ogita M, Takenaka R, Nozawa Y, Watanabe Y, Imae T, Abe O. Sawayanagi S, et al. Among authors: takenaka r. Radiat Oncol. 2022 Feb 23;17(1):41. doi: 10.1186/s13014-022-02008-3. Radiat Oncol. 2022. PMID: 35197092 Free PMC article.
History of whole pelvis plus para-aortic radiation is a risk factor associated with febrile neutropenia during chemotherapy for recurrent cervical cancer.
Nara K, Taguchi A, Tojima Y, Miyamoto Y, Tanikawa M, Sone K, Mori M, Tsuruga T, Yamamoto T, Takenaka R, Takada T, Osuga Y, Suzuki H. Nara K, et al. Among authors: takenaka r. Int J Clin Oncol. 2021 Sep;26(9):1759-1766. doi: 10.1007/s10147-021-01950-8. Epub 2021 Jun 4. Int J Clin Oncol. 2021. PMID: 34086110